Crypto, DeFi, Reviews

Palisade | A Broad Overview of the Digital Asset Custody Landscape, including the Emerging Trends and Challenges

The digital asset custody landscape is largely split into two sectors: third-party custodians and wallet technology providers. This means that either you can trust a third party such as a regulated custodian to hold your money, or you can buy and run the technology provided by a wallet technology provider.

During the earlier days of the industry, there was much emphasis on self-custody, with individuals being responsible or managing their own private keys.

Palisade team thinks this was primarily because at the time a lot of crypto was held by individuals, rather than organizations. But as the industry matured, we saw the shift where more and more institutions and businesses entered the market that wanted to hold crypto. These new players in the industry wanted more than self-custody using a private key. They wanted enhanced security, governance, counterparty management, recovery in case of disaster scenarios and auditability.

The self custody model could not provide all of this – so a model where the custody was managed by a third party was needed.

The third party custodians that emerged focused on customer relationship management but provided basic peer-to-peer payment services at the blockchain level. Institutions and businesses were still getting to grips with blockchain technology, so on-chain features like staking and access to DeFi weren’t a priority. Slowly as the industry further matured, the custodians shifted from basic services to adding additional managed services like staking and on-chain trading, etc.

Today, businesses and institutions are seeking to build complex use-cases such as the issuance and management of real world assets on top of blockchain. We’re seeing regulation maturing in forward-thinking jurisdictions, enabling service providers to offer features that can cater to such use-cases. Custody is no longer about providing basic access to the blockchain. It’s about partnering with customers, providing guidance and unlocking frictionless access to web3.

But there are also some challenges. Digital asset custody is an extremely complex area that is sometimes beyond the technical acumen of traditional financial institutions, including those wanting to move into the crypto space. And while the EU’s MiCA laws provide a good framework, global crypto regulation is struggling to keep pace with the development of the sector. This can make it tricky for businesses located in certain jurisdictions to play by the rules.

Why the EU’s new MiCA laws boost its ambition to become a global hub in crypto;

MiCA provides the regulatory clarity that crypto businesses are looking for. It outlines licensing requirements, capital adequacy, and consumer protection measures, giving companies a roadmap for compliance. It also creates a single rulebook across all EU member states and once a business is licensed in one EU jurisdiction, it can offer services throughout the bloc. This streamlines operations compared to other jurisdictions.

However, it still has some gaps that need to be addressed. It lacks more granular guidelines for DeFi and NFTs. There is a lot of potential here for real-world asset (RWA) issuance, on-chain copyright and digital rights management (DRM), etc that will be possible to unlock once the regulatory clarity is there. Consumer protections also need to be strengthened. Stronger cybersecurity requirements and AML-CTF regime across the board will help address some of these issues.

From what the Palisade team knows so far, MiCA 2.0 aims to target most of this, providing clarity for financial and crypto businesses to innovate across Europe. Most of the innovation today is happening outside regulation, which, although due to lack of regulation, is not in the best interests of the parties involved.

If we want mass adoption, we need better clarity through a regime that fosters innovation while ensuring a fair playing field. Right now, from what we know at Palisade, Europe’s MiCA is a step in the right direction.

Their experience in the Web3 space and expert insights on the industry as well as its evolution; The founding story of Palisade and what its upcoming plans are.

For context: Tom and Manthan from Palisade met when working as Staff Software Engineers at Ripple, a leading provider of cross-border payment and digital asset custody solutions.

“We noticed an opportunity to create a new, but different platform in the crypto asset custody space. We saw some larger players offering a “one size fits all” approach, which isn’t always the easiest for traditional businesses to work with. It was clear there was an opportunity to create a new custody platform that not only offers simple, secure and scalable, solutions but also, more importantly, customizable ones. That is why we took the leap and left our day jobs to build Palisade.”, Tom and Manthan say.

“This is a major year of growth for us. We have spent the last two years building the platform and the business infrastructure to support it. 2024 is about working with our clients to develop next-generation, innovative solutions.

“We also have a major focus on the tokenization of real-world assets. There is an increasing number of businesses that want to tokenize unique assets on the blockchain. But there is a lack of understanding and ability to do so. We help our customers mint and manage digital tokens for various applications, such as carbon credits and gold.”

PostAd_coinrule_banner728x90

Leave a Comment

Your email address will not be published. Required fields are marked *

*

Keiretsu Forum Announces Dr. Martin Gershon as Keynote Speaker for 2024 Investor Capital Expo

2024-10-02T11:08:00Z

PHILADELPHIA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Keiretsu Forum, the world's largest and most active accredited angel investor network, is proud to announce that Dr. Martin Gershon, a prominent leader in healthcare innovation and venture capital, will deliver the keynote address at the 2024 Investor Capital Expo. This signature event in early-stage investment community will be held on October 31, 2024, at Convene City View in Philadelphia.

Dr. Gershon, Managing Partner and Chief Investment Officer of Endeavor Venture Funds and Endeavor Venture Studio, brings over two decades of experience in life sciences and healthcare startups. His leadership at Endeavor has resulted in over 100 investments and 24 successful exits, solidifying his reputation as a strategic force in healthcare investment. Under his guidance, Endeavor Venture Funds has become synonymous with cutting-edge innovation, most recently, in artificial intelligence (AI)-powered drug discovery.

Recognized as a "Top Voice" in Venture Capital and Entrepreneurship by LinkedIn and named a Top 100 Healthcare Industry Leader by Standard & Poor’s, Dr. Gershon is a sought-after advisor and speaker. His keynote, titled "Pioneering Healthcare Innovation: Investment Strategies in AI Drug Discovery," will delve into the transformative impact of AI on the drug development process. His address will focus on:

  • Investment Opportunities: Exploring high-growth potential in AI-driven drug discovery.
  • Strategic Insights: Understanding how AI is accelerating the development of novel therapeutics.
  • Future Trends: Highlighting upcoming innovations that will shape the life sciences and healthcare sectors.

Keiretsu Forum: A Global Leader in Early-Stage Innovation

Keiretsu Forum continues to be a global leader in early-stage innovation, offering unparalleled access to groundbreaking companies across industries. The Investor Capital Expo serves as the premier gathering for angel investors, venture capitalists, family offices, and entrepreneurs, spotlighting companies that have undergone Keiretsu Forum's rigorous due diligence process. The event provides an invaluable platform for investors to engage with high-potential startups, network with peers, and gain insights from leading industry experts.

Keiretsu Forum has a relationship with Endeavor and Dr Gershon that has at its core aligned vision and lays the solid platform for access to a larger number of remarkable Founder Entrepreneurs and strategic partnerships with the Endeavor investor ecosystem for follow on rounds and sustained growth.

"Dr. Gershon's expertise in healthcare and AI makes him an ideal keynote speaker for this year’s Expo," said Howard Lubert, Regional President of Keiretsu Forum. "His contributions to the commercialization of life-saving technologies and his leadership in AI innovation exemplify the type of visionary thinking that drives the success of early-stage ventures."

Event Details

  • Date: October 31, 2024
  • Time: 8:00 AM – 6:00 PM EDT
  • Location: Convene City View, 30 S 17th St, Philadelphia, PA

Accredited angel investors are encouraged to register for this exclusive event, where they can engage with the next wave of industry disruptors and gain key insights from one of healthcare’s leading innovators.

About Keiretsu Forum :

Keiretsu Forum is the world’s largest private equity angel investment network with 2000+ accredited investors in 35 North American and 23 International chapters, who have invested more than $1B in early-stage companies in the last 23 years.

The Keiretsu Forum portfolio features Entrepreneurs and Companies from Technology-(Internet, Software, Cyber Security, SaaS, Mobile Systems, IoT, etc.), Life Sciences-(Pharma, Medical Devices, Health IT, etc.), FinServ/FinTech, Consumer Products, Clean-Green Energy, Consumer Products, & more!

About Dr. Martin Gershon

Dr. Gershon's career has been marked by his pioneering efforts in healthcare and life sciences innovation. His role at Endeavor Venture Funds connects emerging companies with Fortune 500 partnerships, offering strategic growth solutions and regulatory expertise. Dr. Gershon has advised numerous organizations, including the White House Moonshot CancerX Accelerator, Goldman Sachs, and Bain Capital.

Dr. Gershon’s academic credentials are equally impressive, with advanced training in neuroscience, oncology, and immunology from Harvard, McGill, and Columbia. He has also served as an FDA attorney and has been honored as a Google Scholar in Entrepreneurship.

For media inquiries, please contact:

Cindi Sutera
AMS Communications
[email protected]
610-613-2773


GlobeNewsWire News

Recent Comments